Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Evaluations of the Public Health Impact of Adult Vaccination with Pneumococcal Vaccines Should Include Reductions in All-Cause Pneumonia.

Theilacker C, Vyse A, Jodar L, Gessner BD.

Clin Infect Dis. 2019 Sep 7. pii: ciz882. doi: 10.1093/cid/ciz882. [Epub ahead of print] No abstract available.

PMID:
31624826
2.

Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study.

Kern WV, Roth JA, Bertz H, Götting T, Dettenkofer M, Widmer AF, Theilacker C; Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group (ONKO-KISS).

Transpl Infect Dis. 2019 Oct 1:e13186. doi: 10.1111/tid.13186. [Epub ahead of print]

PMID:
31574202
3.

Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial.

Gessner BD, Theilacker C, Jodar L.

Vaccine. 2019 Aug 14;37(35):4853-4857. doi: 10.1016/j.vaccine.2019.07.040. Epub 2019 Jul 18.

4.

Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.

Widmer AF, Kern WV, Roth JA, Dettenkofer M, Goetting T, Bertz H, Theilacker C; Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group (ONKO-KISS).

Infection. 2019 Oct;47(5):837-845. doi: 10.1007/s15010-019-01327-0. Epub 2019 Jun 11.

PMID:
31187401
5.

Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.

Schmedt N, Heuer OD, Häckl D, Sato R, Theilacker C.

BMC Health Serv Res. 2019 Jan 14;19(1):30. doi: 10.1186/s12913-018-3861-8.

6.

Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014.

Kern WV, Weber S, Dettenkofer M, Kaier K, Bertz H, Behnke M, Weisser M, Götting T, Widmer AF, Theilacker C; Hospital Infection Surveillance System for Patients with Haematologic/Oncologic Malignancies Study Group (ONKO-KISS).

J Infect. 2018 Jul;77(1):68-74. doi: 10.1016/j.jinf.2018.05.004. Epub 2018 Jun 6.

PMID:
29883599
7.

Time-dependent differences in management and microbiology of orthopaedic internal fixation-associated infections: an observational prospective study with 229 patients.

Kuehl R, Tschudin-Sutter S, Morgenstern M, Dangel M, Egli A, Nowakowski A, Suhm N, Theilacker C, Widmer AF.

Clin Microbiol Infect. 2019 Jan;25(1):76-81. doi: 10.1016/j.cmi.2018.03.040. Epub 2018 Apr 10.

PMID:
29649599
8.

Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease.

Theilacker C, Hilton B, Jiang Q, Gessner BD, Jodar L.

Clin Infect Dis. 2018 May 2;66(10):1641-1642. doi: 10.1093/cid/cix1113. No abstract available.

PMID:
29272332
9.

Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).

Weisser M, Theilacker C, Tschudin Sutter S, Babikir R, Bertz H, Götting T, Dettenkofer M, Kern WV, Widmer AF; Hospital Infection Surveillance System for Patients With Haematologic/Oncologic Malignancies Study Group (ONKO-KISS).

Clin Microbiol Infect. 2017 Nov;23(11):854-859. doi: 10.1016/j.cmi.2017.03.020. Epub 2017 Mar 31.

10.

Importance of Local Epidemiology in Prevalence and Resistance of Cystic Fibrosis-related Pathogens.

Hufnagel M, König S, Theilacker C.

Pediatr Infect Dis J. 2016 Feb;35(2):229. doi: 10.1097/INF.0000000000000982. No abstract available.

PMID:
26756270
11.

Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study.

Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bögelein M, Bahr V, Rusch S, Pohl A, Kogelmann K, Frieseke S, Bogdanski R, Brunkhorst FM, Kern WV.

Clin Infect Dis. 2016 Apr 1;62(7):871-878. doi: 10.1093/cid/civ1195. Epub 2015 Dec 23.

PMID:
26703862
12.

Correction: Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune Response.

Theilacker C, Diederich AK, Otto A, Sava IG, Wobser D, Bao Y, Hese K, Broszat M, Henneke P, Becher D, Huebner J.

PLoS One. 2015 Aug 24;10(8):e0136806. doi: 10.1371/journal.pone.0136806. eCollection 2015. No abstract available.

13.

Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune Response.

Theilacker C, Diederich AK, Otto A, Sava IG, Wobser D, Bao Y, Hese K, Broszat M, Henneke P, Becher D, Huebner J.

PLoS One. 2015 Jul 14;10(7):e0132949. doi: 10.1371/journal.pone.0132949. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0136806.

14.

Photo Quiz: Mysterious Objects in a Pleural Biopsy Sample from a Patient with Recurrent Pleural Empyema.

Held J, Gräber K, Leubner-Metzger G, Kunkel T, Theilacker C, Kramme S, Schmitt-Graeff A.

J Clin Microbiol. 2015 Jul;53(7):2005, 2393. doi: 10.1128/JCM.02074-13. No abstract available.

15.

[Update pneumococcal infections].

Theilacker C.

Pneumologie. 2014 Oct;68(10):662-5. doi: 10.1055/s-0034-1377567. Epub 2014 Oct 7. Review. German.

16.

Detection of opsonic antibodies against Enterococcus faecalis cell wall carbohydrates in immune globulin preparations.

Hufnagel M, Sixel K, Hammer F, Kropec A, Sava IG, Theilacker C, Berner R, Huebner J.

Infection. 2014 Aug;42(4):749-55. doi: 10.1007/s15010-014-0628-y. Epub 2014 May 23.

PMID:
24854332
17.

Microarray-based genotyping and clinical outcomes of Staphylococcus aureus bloodstream infection: an exploratory study.

Rieg S, Jonas D, Kaasch AJ, Porzelius C, Peyerl-Hoffmann G, Theilacker C, Küpper MF, Schneider C, Seifert H, Kern WV.

PLoS One. 2013 Aug 14;8(8):e71259. doi: 10.1371/journal.pone.0071259. eCollection 2013.

18.

[Prevention of sepsis after splenectomy].

Theilacker C, Kern WV.

Dtsch Med Wochenschr. 2013 Aug;138(34-35):1729-33. doi: 10.1055/s-0033-1343335. Epub 2013 Aug 9. Review. German. No abstract available.

PMID:
23934593
19.

Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlates.

Theilacker C, Held J, Allering L, Emmerich P, Schmidt-Chanasit J, Kern WV, Panning M.

BMC Infect Dis. 2013 Aug 8;13:369. doi: 10.1186/1471-2334-13-369.

20.

[Pneumococcal vaccination in adults: background of the current discussion].

Pletz MW, van der Linden M, Fobiwe JP, Theilacker C.

Dtsch Med Wochenschr. 2013 Feb;138(5):185-7. doi: 10.1055/s-0032-1327411. Epub 2013 Jan 22. German. No abstract available.

PMID:
23340936
21.

Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin.

Geiss-Liebisch S, Rooijakkers SH, Beczala A, Sanchez-Carballo P, Kruszynska K, Repp C, Sakinc T, Vinogradov E, Holst O, Huebner J, Theilacker C.

J Biol Chem. 2012 Nov 2;287(45):37769-77. doi: 10.1074/jbc.M112.358283. Epub 2012 Aug 20.

22.

Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.

Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB.

Clin Infect Dis. 2012 Nov;55(9):1188-97. doi: 10.1093/cid/cis624. Epub 2012 Jul 17.

23.

Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis.

Bao Y, Sakinc T, Laverde D, Wobser D, Benachour A, Theilacker C, Hartke A, Huebner J.

PLoS One. 2012;7(6):e38458. doi: 10.1371/journal.pone.0038458. Epub 2012 Jun 18.

24.

The structure of the wall teichoic acid isolated from Enterococcus faecalis strain 12030.

Theilacker C, Holst O, Lindner B, Huebner J, Kaczyński Z.

Carbohydr Res. 2012 Jun 1;354:106-9. doi: 10.1016/j.carres.2012.03.031. Epub 2012 Apr 3.

PMID:
22551470
25.

Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.

Theilacker C, Kropec A, Hammer F, Sava I, Wobser D, Sakinc T, Codée JD, Hogendorf WF, van der Marel GA, Huebner J.

J Infect Dis. 2012 Apr 1;205(7):1076-85. doi: 10.1093/infdis/jis022. Epub 2012 Feb 23.

PMID:
22362863
26.

Chemical structure of wall teichoic acid isolated from Enterococcus faecium strain U0317.

Bychowska A, Theilacker C, Czerwicka M, Marszewska K, Huebner J, Holst O, Stepnowski P, Kaczyński Z.

Carbohydr Res. 2011 Dec 13;346(17):2816-9. doi: 10.1016/j.carres.2011.09.026. Epub 2011 Oct 2.

PMID:
22024569
27.

Tick-borne lymphadenopathy (TIBOLA) acquired in Southwestern Germany.

Rieg S, Schmoldt S, Theilacker C, de With K, Wölfel S, Kern WV, Dobler G.

BMC Infect Dis. 2011 Jun 10;11:167. doi: 10.1186/1471-2334-11-167.

28.

Deletion of the glycosyltransferase bgsB of Enterococcus faecalis leads to a complete loss of glycolipids from the cell membrane and to impaired biofilm formation.

Theilacker C, Sava I, Sanchez-Carballo P, Bao Y, Kropec A, Grohmann E, Holst O, Huebner J.

BMC Microbiol. 2011 Apr 6;11:67. doi: 10.1186/1471-2180-11-67.

29.

Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.

Theilacker C, Kaczyński Z, Kropec A, Sava I, Ye L, Bychowska A, Holst O, Huebner J.

PLoS One. 2011 Mar 18;6(3):e17839. doi: 10.1371/journal.pone.0017839.

30.

Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient.

Geyer M, Wilpert J, Wiech T, Theilacker C, Stubanus M, Kramer-Zucker A, Fischer KG, Drognitz O, Frydrychowicz A, Kern W, Walz G, Pisarski P.

Transpl Infect Dis. 2011 Jun;13(3):278-84. doi: 10.1111/j.1399-3062.2010.00583.x. Epub 2010 Oct 26.

PMID:
20977568
31.

Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection.

Sava IG, Heikens E, Kropec A, Theilacker C, Willems R, Huebner J.

J Med Microbiol. 2010 Sep;59(Pt 9):1001-4. doi: 10.1099/jmm.0.020578-0. Epub 2010 Jun 3.

PMID:
20522627
32.

Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak.

Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV.

Infection. 2009 Dec;37(6):540-3. doi: 10.1007/s15010-009-9023-5.

PMID:
19669085
33.

Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany.

Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hübner J, Dettenkofer M, Kaasch A, Seifert H, Schneider C, Kern WV.

J Infect. 2009 Oct;59(4):232-9. doi: 10.1016/j.jinf.2009.07.015. Epub 2009 Aug 3.

PMID:
19654021
34.

Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells.

Sava IG, Zhang F, Toma I, Theilacker C, Li B, Baumert TF, Holst O, Linhardt RJ, Huebner J.

J Biol Chem. 2009 Jul 3;284(27):18194-201. doi: 10.1074/jbc.M901460200. Epub 2009 Apr 23.

35.

[Prevention of infections and thromboses after splenectomy or because of functional loss of the spleen].

Engelhardt M, Haas PS, Theilacker C, Eber SW, Schmugge M, Kern WV, Heimpel H.

Dtsch Med Wochenschr. 2009 Apr;134(17):897-902. doi: 10.1055/s-0029-1220231. Epub 2009 Mar 31. Review. German.

PMID:
19337961
36.

Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis.

Theilacker C, Sanchez-Carballo P, Toma I, Fabretti F, Sava I, Kropec A, Holst O, Huebner J.

Mol Microbiol. 2009 Feb;71(4):1055-69. doi: 10.1111/j.1365-2958.2009.06587.x.

37.

[Ulcerous colitis and infection with cytomegalovirus, herpes simplex virus and clostridium difficile].

Arnold C, von Sanden S, Theilacker C, Blum HE.

Z Gastroenterol. 2008 Aug;46(8):780-3. doi: 10.1055/s-2008-1027154. German.

PMID:
18759202
38.

Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis.

Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, Theilacker C, Hübner J, Santos-Sierra S, Teti G, Golenbock DT, Poyart C, Trieu-Cuot P.

J Immunol. 2008 May 1;180(9):6149-58. Erratum in: J Immunol. 2009 Feb 15;182(4):2551.

39.

[African tick bite fever].

Rieg S, Theilacker C.

Dtsch Med Wochenschr. 2008 Feb;133(8):363-4. doi: 10.1055/s-2008-1046720. German. No abstract available.

PMID:
18270918
40.

Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.

Theilacker C, Kaczynski Z, Kropec A, Fabretti F, Sange T, Holst O, Huebner J.

Infect Immun. 2006 Oct;74(10):5703-12.

41.

Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides.

Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A, Holst O, Huebner J.

Infect Immun. 2006 Jul;74(7):4164-71.

42.

Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.

Hufnagel M, Kropec A, Theilacker C, Huebner J.

Clin Diagn Lab Immunol. 2005 Aug;12(8):930-4.

43.

Rationale for the development of immunotherapy regimens against enterococcal infections.

Theilacker C, Krueger WA, Kropec A, Huebner J.

Vaccine. 2004 Dec 6;22 Suppl 1:S31-8. Review.

PMID:
15576199
44.

Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.

Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L.

J Immunol. 2004 Nov 1;173(9):5671-8. Erratum in: J Immunol. 2007 Jun 1;178(11):7485.

45.

Serological and genetic diversity of capsular polysaccharides in Enterococcus faecalis.

Hufnagel M, Hancock LE, Koch S, Theilacker C, Gilmore MS, Huebner J.

J Clin Microbiol. 2004 Jun;42(6):2548-57.

46.

Enterococcal infections: host response, therapeutic, and prophylactic possibilities.

Koch S, Hufnagel M, Theilacker C, Huebner J.

Vaccine. 2004 Feb 17;22(7):822-30. Review.

PMID:
15040934
47.

Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.

Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB.

Infect Immun. 2003 Jul;71(7):3875-84.

48.

Lymphocyte subsets in peripheral blood and smoking habits.

Schaberg T, Theilacker C, Nitschke OT, Lode H.

Lung. 1997;175(6):387-94.

PMID:
9330248

Supplemental Content

Loading ...
Support Center